Clinical Trial

Prognostic Impacts of Lipid Profile and BMI in Adult AML

Study acronym: AML/BMI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the changes in lipid profile parameters (total cholesterol, triglycerides, HDL-C, and LDL-C) in adult AML patients before and after intensive induction chemotherapy. The main questions it aims to answer are: * Are there correlations between metabolic changes (in lipid profile and BMI) and treatment outcomes, including remission status and incidence of chemotherapy-related complications? * Can the baseline lipid profile and BMI serve as prognostic markers for response to induction chemotherapy.? Participants will be observed before and after induction chemotherapy regarding their lipid profile, and BMI, observing any correlations between the different results with any complications, and with remission status.
Trial Details
NCT Number NCT07143877
Lead Sponsor Assiut University
Conditions AML (Acute Myeloid Leukemia), BMI, Lipid Profile, Induction Chemotherapy
Enrollment 200 participants
Start Date 2025-11-15
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-27